Home LiteratureArticle Details
PMID: 8387398 Published · ppublish English Journal Article Review

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives.

Cancer chemotherapy and pharmacology ·Vol. 32 ·No. 2 ·1993-00-00 ·Pages 103-8

Pommier Y

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/pharmacology,therapeutic use Binding Sites Camptothecin/analogs & derivatives,metabolism,pharmacology,therapeutic use Cell Differentiation/drug effects DNA Repair/drug effects Drug Design Drug Resistance Drug Screening Assays, Antitumor Humans Neoplasms/drug therapy Topoisomerase I Inhibitors Topoisomerase II Inhibitors
Chemicals
Antineoplastic Agents Topoisomerase I Inhibitors Topoisomerase II Inhibitors Camptothecin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Pommier Y
Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
References (92)
92 references, click to expand
  1. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination.
    Science. 1985 Nov 22;230(4728):954-8 PMID: 2997924
  2. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7654-8 PMID: 1652758
  3. Effect of 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants.
    Cancer Res. 1991 Apr 1;51(7):1755-9 PMID: 1848478
  4. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
    J Mol Biol. 1991 Dec 20;222(4):909-24 PMID: 1662289
  5. Recent studies of DNA topoisomerases.
    Biochim Biophys Acta. 1987 Jun 6;909(1):1-9 PMID: 3034331
  6. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe.
    Cell. 1987 Sep 11;50(6):917-25 PMID: 3040264
  7. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
    Proc Natl Acad Sci U S A. 1987 May;84(10 ):3185-8 PMID: 3033639
  8. Acidic phospholipids directly inhibit DNA binding of mammalian DNA topoisomerase I.
    FEBS Lett. 1990 Feb 12;261(1):151-4 PMID: 2155130
  9. In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4142-6 PMID: 2987966
  10. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Cancer Commun. 1989;1(4):217-24 PMID: 2576973
  11. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.
    Mol Gen Genet. 1990 Mar;221(1):27-32 PMID: 2157956
  12. Supercoiling of intracellular DNA can occur in eukaryotic cells.
    Cell. 1988 Dec 2;55(5):849-56 PMID: 2847873
  13. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
    J Biol Chem. 1985 Nov 25;260(27):14873-8 PMID: 2997227
  14. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
    Nucleic Acids Res. 1991 Nov 11;19(21):5973-80 PMID: 1658748
  15. Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiae.
    J Mol Biol. 1989 Jul 20;208(2):257-67 PMID: 2549254
  16. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA.
    Nucleic Acids Res. 1991 Jun 25;19(12):3295-300 PMID: 1905803
  17. Characterization of a camptothecin-resistant human DNA topoisomerase I.
    J Biol Chem. 1988 Mar 15;263(8):3912-6 PMID: 2831213
  18. DNA topoisomerase poisons as antitumor drugs.
    Annu Rev Biochem. 1989;58:351-75 PMID: 2549853
  19. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor.
    AIDS Res Hum Retroviruses. 1991 Jan;7(1):65-72 PMID: 1707642
  20. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.
    Proc Natl Acad Sci U S A. 1988 Apr;85(8):2543-7 PMID: 2833744
  21. Antitumor agents. 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analogues.
    J Med Chem. 1986 Aug;29(8):1547-50 PMID: 3016271
  22. Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line.
    Biochem Pharmacol. 1989 Jan 15;38(2):263-9 PMID: 2464346
  23. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA.
    EMBO J. 1985 May;4(5):1237-43 PMID: 2988941
  24. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
    J Biol Chem. 1991 Oct 25;266(30):20418-23 PMID: 1657924
  25. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.
    Biochemistry. 1989 Oct 3;28(20):8154-60 PMID: 2557897
  26. Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide.
    Eur J Cancer. 1990;26(5):590-3 PMID: 2169277
  27. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
    NCI Monogr. 1987;(4):117-21 PMID: 3041238
  28. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Nucleic Acids Res. 1988 Dec 9;16(23):11157-70 PMID: 2849758
  29. 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells.
    Cancer Commun. 1990;2(12):395-400 PMID: 2176090
  30. Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells.
    Biochem Pharmacol. 1991 Jun 21;42(1):77-85 PMID: 1648924
  31. Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship.
    Biochemistry. 1984 Mar 13;23(6):1183-8 PMID: 6712942
  32. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors.
    Cancer Res. 1987 Nov 15;47(22):5944-7 PMID: 3664496
  33. Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse.
    Cancer Res. 1990 Mar 15;50(6):1715-20 PMID: 2306725
  34. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.
    Nucleic Acids Res. 1990 Nov 25;18(22):6611-9 PMID: 2174543
  35. DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts.
    Science. 1989 Nov 24;246(4933):1046-8 PMID: 2555920
  36. Mode of action of the new quinolones: new data.
    Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31 PMID: 1650698
  37. E-ring desoxy analogues of etoposide.
    J Med Chem. 1989 Jul;32(7):1418-20 PMID: 2738876
  38. Disassembly of the nucleus in mitotic extracts: membrane vesicularization, lamin disassembly, and chromosome condensation are independent processes.
    Cell. 1987 Jan 30;48(2):219-30 PMID: 3026636
  39. Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression.
    Biochemistry. 1989 Nov 14;28(23):9104-10 PMID: 2557917
  40. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity.
    Cancer Res. 1989 Mar 15;49(6):1465-9 PMID: 2538227
  41. DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA.
    J Biol Chem. 1983 Aug 10;258(15):9536-43 PMID: 6308011
  42. Teniposide, a topoisomerase II inhibitor, prevents chromosome condensation and separation but not decondensation in fertilized surf clam (Spisula solidissima) oocytes.
    Dev Biol. 1990 Nov;142(1):224-32 PMID: 2172057
  43. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.
    Biochem Pharmacol. 1987 Oct 15;36(20):3477-86 PMID: 2823823
  44. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Cancer Res. 1989 Nov 1;49(21):5870-8 PMID: 2790800
  45. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.
    J Virol. 1991 May;65(5):2381-92 PMID: 1850018
  46. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
    Cancer Res. 1989 Sep 15;49(18):5077-82 PMID: 2548710
  47. Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.
    J Biol Chem. 1987 Dec 5;262(34):16739-47 PMID: 2824504
  48. Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8740-3 PMID: 1681541
  49. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.
    Science. 1984 Oct 26;226(4673):466-8 PMID: 6093249
  50. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
    Cancer Res. 1989 Aug 15;49(16):4385-9 PMID: 2545341
  51. Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.
    J Biol Chem. 1985 Feb 25;260(4):2475-82 PMID: 2982821
  52. Transcription generates positively and negatively supercoiled domains in the template.
    Cell. 1988 May 6;53(3):433-40 PMID: 2835168
  53. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
    Cancer Res. 1988 Jun 1;48(11):3230-5 PMID: 2835157
  54. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.
    Biochemistry. 1986 Jan 14;25(1):9-16 PMID: 3006754
  55. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
    Cancer Res. 1989 Nov 15;49(22):6365-8 PMID: 2553254
  56. Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation.
    Cancer Res. 1990 Sep 1;50(17 Suppl):5649S-5652S PMID: 2167162
  57. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
    Cancer Res. 1985 Jul;45(7):3143-9 PMID: 2988762
  58. DNA topoisomerases: why so many?
    J Biol Chem. 1991 Apr 15;266(11):6659-62 PMID: 1849888
  59. Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.
    Nucleic Acids Res. 1991 Jun 11;19(11):2861-8 PMID: 1647520
  60. Purification and properties of type II DNA topoisomerase from embryos of Drosophila melanogaster.
    Methods Enzymol. 1983;100:161-70 PMID: 6312257
  61. Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants.
    Cell. 1988 Jul 29;54(3):403-11 PMID: 2840207
  62. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6280-5 PMID: 1933888
  63. DNA topoisomerases.
    Annu Rev Biochem. 1985;54:665-97 PMID: 2992360
  64. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA.
    Nature. 1987 Mar 26-Apr 1;326(6111):414-6 PMID: 2436053
  65. Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.
    Cancer Res. 1991 Sep 1;51(17):4729-31 PMID: 1651812
  66. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
    J Cell Biol. 1990 Nov;111(5 Pt 1):1753-62 PMID: 2172257
  67. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Cancer Res. 1988 Feb 1;48(3):512-6 PMID: 2825977
  68. Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
    Biochemistry. 1990 Jan 16;29(2):562-9 PMID: 2154250
  69. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster.
    Cell. 1986 Aug 15;46(4):521-30 PMID: 3015418
  70. DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.
    Proc Natl Acad Sci U S A. 1984 May;81(9):2616-20 PMID: 6326134
  71. Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome.
    Proc Natl Acad Sci U S A. 1984 Nov;81(22):6958-62 PMID: 6095263
  72. DNA topoisomerases from rat liver: physiological variations.
    Nucleic Acids Res. 1983 Feb 25;11(4):1059-75 PMID: 6298730
  73. DNA topoisomerases as potential targets of antiviral action.
    Pharmacol Ther. 1989;43(3):377-95 PMID: 2554345
  74. Characterization of the 3' region of the human DNA topoisomerase I gene.
    Cancer Res. 1989 Jul 15;49(14):3922-7 PMID: 2544263
  75. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22.
    Proc Natl Acad Sci U S A. 1988 Oct;85(19):7177-81 PMID: 2845399
  76. Topoisomerase II is a structural component of mitotic chromosome scaffolds.
    J Cell Biol. 1985 May;100(5):1706-15 PMID: 2985625
  77. A homogeneous type II DNA topoisomerase from HeLa cell nuclei.
    J Biol Chem. 1981 Sep 10;256(17):9334-9 PMID: 6267071
  78. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I.
    Nucleic Acids Res. 1989 Nov 11;17(21):8521-32 PMID: 2555774
  79. DNA topoisomerase II is required at the time of mitosis in yeast.
    Cell. 1985 Jun;41(2):553-63 PMID: 2985283
  80. DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.
    Cancer Res. 1988 Sep 15;48(18):5096-100 PMID: 2842045
  81. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.
    Science. 1986 Feb 14;231(4739):737-40 PMID: 3003910
  82. Single-strand DNA cleavages by eukaryotic topoisomerase II.
    Biochemistry. 1988 Nov 1;27(22):8369-79 PMID: 2853964
  83. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    Cancer Res. 1990 Nov 1;50(21):6919-24 PMID: 1698546
  84. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Cancer Res. 1986 Jun;46(6):3075-81 PMID: 3009009
  85. Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle.
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7580-4 PMID: 1652754
  86. Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.
    Cancer Res. 1991 Nov 15;51(22):6039-44 PMID: 1682041
  87. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
    Cancer Res. 1990 Nov 15;50(22):7116-22 PMID: 2171756
  88. Abrogation of etoposide-mediated cytotoxicity by cycloheximide.
    Biochem Pharmacol. 1988 Mar 15;37(6):1117-22 PMID: 3355586
  89. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9431-5 PMID: 2556712
  90. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.
    Cancer Chemother Rep. 1972 Aug;56(4):515-21 PMID: 5081595
  91. Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):8910-3 PMID: 2848244
  92. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):1086-90 PMID: 2829215
Article Info
Journal
Cancer chemotherapy and pharmacology
Abbr.
Cancer Chemother Pharmacol
ISSN
0344-5704
DOI
10.1007/BF00685611
Published
1993-00-00
Pages
103-8
Language
English
Region
Germany
NLM ID
7806519
Subset
IM
External Links
PubMed source DOI: 10.1007/BF00685611 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2